NIKE INC -CL B (NKE)       105.96  -0.69 (-0.65%)

105.96  -0.69 (-0.65%)

US6541061031 - Common Stock - After market: 105.96 0 (0%)


Fundamental Rating

5

Overall NKE gets a fundamental rating of 5 out of 10. We evaluated NKE against 49 industry peers in the Textiles, Apparel & Luxury Goods industry. NKE scores excellent points on both the profitability and health parts. This is a solid base for a good stock. NKE is quite expensive at the moment. It does show a decent growth rate.




Profitability

Profitability Rating

7

NKE's Return On Assets of 13.73% is amongst the best returns of the industry. NKE outperforms 83% of its industry peers. The industry average Return On Assets is 4.94%.
NKE's Return On Equity of 35.65% is amongst the best of the industry. NKE does better than the industry average Return On Equity of 23.41%.

NKE's Profit Margin of 11.96% is amongst the best returns of the industry. NKE outperforms 81% of its industry peers. The industry average Profit Margin is 5.39%.
The Piotroski-F score of NKE is 5.00. This is a neutral score and indicates average health and profitability for NKE.
VS Industry

ROA (13.73%) VS Industry: 83% outperformed.

-114.87
22.39

ROE (35.65%) VS Industry: 78% outperformed.

0.20
114.27

Profit Margin (11.96%) VS Industry: 81% outperformed.

-184.15
19.11

Valuation

Valuation Rating

0

With a price book ratio of 10.48, NKE is valued correctly.
With a Price/Earnings Ratio of 30.02, NKE can be considered very expensive at the moment.
With a Price/Earning Ratio of 30.02, NKE is valued a higher than the industry average, which is at 11.00. 89% of the companies listed in the same industry are cheaper than NKE!
The Forward Price/Earnings Ratio of 27.69 indicates a quite expensive current valuation of NKE.

The high PEG Ratio, which compensates the Price/Earnings for growth, indicates an expensive valuation of the company.
When comparing the price book ratio of NKE to the average industry price book ratio of 2.12, NKE is valued more expensive than its industry peers. 96% of the companies listed in the same industry are valued cheaper.
When comparing the Enterprise Value to EBITDA ratio of NKE to the average industry ratio of 7.80, NKE is valued more expensive than its industry peers. 91% of the companies listed in the same industry are valued cheaper.
VS Industry

Price/Earnings (30.02) VS Industry: 11% outperformed.

267.50
4.85

Price/Book (10.48) VS Industry: 4% outperformed.

16.11
0.08

Enterprise Value/ EBITDA (22.42) VS Industry: 9% outperformed.

283.08
3.20

Growth

Growth Rating

5

The Earnings Per Share is expected to grow by 13.41% on average over the next 5 years. This is quite good.
When comparing the EPS growth rate of the last 5 years to the growth rate of the upcoming 5 years, we see that the growth is accelerating.
NKE shows a slight negative growth in Earnings Per Share. In the last year, the EPS has decreased by -6.37%.
Measured over the past 5 years, NKE shows a small growth in Earnings Per Share. The EPS has been growing by 8.42% on average per year.

Looking at the last year, NKE shows a small growth in Revenue. The Revenue has grown by 2.07% in the last year.
Measured over the past 5 years, NKE shows a small growth in Revenue. The Revenue has been growing by 6.34% on average per year.
Based on estimates for the next 5 years, NKE will show a small growth in Revenue. The Revenue will grow by 5.38% on average per year.
When comparing the Revenue growth rate of the last years to the growth rate of the upcoming 5 years, we see that the growth is stable.

PastFuture
5Y3Y1Y1Y2Y3Y5Y
EPS8.42% 14.73% -6.37% -20.15% 0.88% 7.14% 13.41%
Revenue6.34% 6.09% 2.07% 4.96% 6.55% 7.36% 5.38%

Health

Health Rating

7

A Current Ratio of 2.64 indicates that NKE has no problem at all paying its short term obligations.
NKE is better placed than average in its industry to meet its short term obligations. Its Current Ratio is much better than the industry average of 2.34.
The Quick Ratio of NKE is much better than the industry average of 1.14.
An Altman-Z score of 6.23 indicates that NKE is not in any danger for bankruptcy at the moment.

NKE has one of the better Altman-Z scores in its industry. It is much better than the industry average of 2.89. NKE has a better score than 89% of its industry peers.
NKE has a Quick Ratio of 1.76. This is a normal value and indicates that NKE is financially healthy and should not expect problems in meeting its short term obligations.
The Piotroski-F score of NKE is 5.00. This is a neutral score and indicates average health and profitability for NKE.
Compared to an average industry Debt to Equity Ratio of 0.37, NKE is more dependent on financing than its industry peers.
VS Industry

Debt/Equity (0.56) VS Industry: 38% outperformed.

5.42
0.00

Quick Ratio (1.76) VS Industry: 77% outperformed.

0.06
4.17

Current Ratio (2.64) VS Industry: 68% outperformed.

0.38
7.90

Altman-Z (6.23) VS Industry: 89% outperformed.

-67.52
16.89

Dividend

Dividend Rating

5

The dividend of NKE is nicely growing with an annual growth rate of 11.36%!
NKE pays out 33.37% of its income as dividend. This is a sustainable payout ratio.
NKE has been paying a dividend for at least 10 years, so it has a reliable track record.
NKE has a Yearly Dividend Yield of 1.29%.

Compared to an average industry Dividend Yield of 3.43, NKE's dividend is way lower than its industry peers. On top of this 96% of the companies listed in the same industry pay a better dividend than NKE!
Compared to an average S&P500 Dividend Yield of 2.47, NKE's dividend is way lower than the S&P500 average.
NKE's earnings are growing slower than its dividend. This means the dividend growth is not sustainable.
VS Industry

Dividend Yield (1.29%) VS Industry: 4% outperformed.

0.25
8.88
NKE Daily chart

NIKE INC -CL B105.96

NYSE:NKE (11/25/2022, 7:17:51 PM)-0.69 (-0.65%)

After market: 105.96 0 (0%)

Chartmill FA Rating
GICS Sector Consumer Discretionary
GICS IndustryGroup Consumer Durables & Apparel
GICS Industry Textiles, Apparel & Luxury Goods
Earnings (Last) 09-29 2022-09-29/amc Earnings (Next) 12-20 2022-12-20/amc
Ins Owners 0.14% Inst Owners 146.23%
Market Cap 165.79B Analysts 76.67
Valuation
PE 30.02 Fwd PE 27.69
PEG (NY) N/A PEG (5Y) 3.57
P/S 3.52 P/B 10.48
EV/EBITDA 22.42
Dividend
Dividend Yield 1.29% Dividend Growth 11.36%
DP 33.37% Ex-Date 12-02 2022-12-02 (0.34)
Growth
EPS 1Y -6.37% EPS 3Y 14.73%
EPS 5Y 8.42% EPS growth Q2Q -19.83%
EPS Next Y -20.15% EPS Next 2Y 0.88%
EPS Next 3Y 7.14% EPS Next 5Y 13.41%
Revenue growth 1Y 2.07% Revenue growth 3Y 6.09%
Revenue growth 5Y 6.34% Revenue growth Q2Q 3.58%
Revenue Next Year 4.96% Revenue Next 2Y 6.55%
Revenue Next 3Y 7.36% Revenue Next 5Y 5.38%
Health
Current Ratio 2.64 Quick Ratio 1.76
Altman-Z 6.23 F-Score 5
Debt/Equity 0.56 WACC 9.72%
ROIC/WACC 3.21
Profitability
ROA 13.73% ROE 35.65%
ROICexgc 31.14% ROIC 18.3%
PM 11.96% OM 13.25%
Asset Turnover 1.15

Fundamental Stock Screener Links

Screen Image

Fundamental Stock Screener

Find stocks with similar Fundamental rating on the USA

Screen Image

Best Fundamental Competitors Stock Screener

Find the competitors with the best fundamentals on the USA

Screen Image

Best Valuation Competitors Stock Screener

Find the competitors with the best valuation on the USA

Screen Image

Best Dividend Competitors Stock Screener

Find the competitors with the best dividend on the USA